Beyond Celiac Investments Announces Investment in Tolerance Bio to Advance Novel Approach in Celiac Disease
BCI’s second investment to advance therapeutic treatments for celiac disease will support preclinical development of novel approach to immune tolerance AMBLER, PA, UNITED STATES, June 22, 2026 /EINPresswire.com/ -- Beyond Celiac Investments (BCI …